BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20051370)

  • 1. Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice.
    Tang JY; Aszterbaum M; Athar M; Barsanti F; Cappola C; Estevez N; Hebert J; Hwang J; Khaimskiy Y; Kim A; Lu Y; So PL; Tang X; Kohn MA; McCulloch CE; Kopelovich L; Bickers DR; Epstein EH
    Cancer Prev Res (Phila); 2010 Jan; 3(1):25-34. PubMed ID: 20051370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
    Elmets CA; Viner JL; Pentland AP; Cantrell W; Lin HY; Bailey H; Kang S; Linden KG; Heffernan M; Duvic M; Richmond E; Elewski BE; Umar A; Bell W; Gordon GB
    J Natl Cancer Inst; 2010 Dec; 102(24):1835-44. PubMed ID: 21115882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of patched-associated susceptibility to radiation induced tumorigenesis by genetic background.
    Pazzaglia S; Mancuso M; Tanori M; Atkinson MJ; Merola P; Rebessi S; Di Majo V; Covelli V; Hahn H; Saran A
    Cancer Res; 2004 Jun; 64(11):3798-806. PubMed ID: 15172986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tazarotene chemoprevention reduces Basal cell carcinoma number and size in Ptch1+/- mice exposed to ultraviolet or ionizing radiation.
    So PL; Lee K; Hebert J; Walker P; Lu Y; Hwang J; Kopelovich L; Athar M; Bickers D; Aszterbaum M; Epstein EH
    Cancer Res; 2004 Jul; 64(13):4385-9. PubMed ID: 15231643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome.
    Tang JY; Chiou AS; Mackay-Wiggan JM; Aszterbaum M; Chanana AM; Lee W; Lindgren JA; Raphael MA; Thompson BJ; Bickers DR; Epstein EH
    Cancer Prev Res (Phila); 2014 Mar; 7(3):292-9. PubMed ID: 24441673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biallelic disruption of the PTCH1 gene in multiple basal cell carcinomas in Japanese patients with nevoid basal cell carcinoma syndrome.
    Tate G; Kishimoto K; Mitsuya T
    Acta Med Okayama; 2014; 68(3):163-70. PubMed ID: 24942795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice.
    Mancuso M; Pazzaglia S; Tanori M; Hahn H; Merola P; Rebessi S; Atkinson MJ; Di Majo V; Covelli V; Saran A
    Cancer Res; 2004 Feb; 64(3):934-41. PubMed ID: 14871823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTCH1 gene mutations in exon 17 and loss of heterozygosity on D9S180 microsatellite in sporadic and inherited human basal cell carcinomas.
    Santos DC; Zaphiropoulos PG; Neto CF; Pimentel ER; Sanches JA; Ruiz IR
    Int J Dermatol; 2011 Jul; 50(7):838-43. PubMed ID: 21699520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome.
    Hasan Ali O; Yurchenko AA; Pavlova O; Sartori A; Bomze D; Higgins R; Ring SS; Hartmann F; Bühler D; Fritzsche FR; Jochum W; Navarini AA; Kim A; French LE; Dermitzakis E; Christiano AM; Hohl D; Bickers DR; Nikolaev SI; Flatz L
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):396-402. PubMed ID: 32564428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique features of PTCH1 mutation spectrum in Chinese sporadic basal cell carcinoma.
    Huang YS; Bu DF; Li XY; Ma ZH; Yang Y; Lin ZM; Lu FM; Tu P; Li H
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):235-41. PubMed ID: 22313357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice.
    Caty V; Liu Y; Viau G; Bissonnette R
    Br J Dermatol; 2006 Apr; 154(4):740-2. PubMed ID: 16536820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice.
    Tang X; Kim AL; Feith DJ; Pegg AE; Russo J; Zhang H; Aszterbaum M; Kopelovich L; Epstein EH; Bickers DR; Athar M
    J Clin Invest; 2004 Mar; 113(6):867-75. PubMed ID: 15067319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of nonsteroidal anti-inflammatory drugs and risk of basal cell carcinoma in the United States Radiologic Technologists study.
    Cahoon EK; Rajaraman P; Alexander BH; Doody MM; Linet MS; Freedman DM
    Int J Cancer; 2012 Jun; 130(12):2939-48. PubMed ID: 21780102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translating cyclooxygenase signaling in patch heterozygote mice into a randomized clinical trial in basal cell carcinoma.
    Arbiser JL
    Cancer Prev Res (Phila); 2010 Jan; 3(1):4-7. PubMed ID: 20051366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTCH1 gene haplotype association with basal cell carcinoma after transplantation.
    Begnini A; Tessari G; Turco A; Malerba G; Naldi L; Gotti E; Boschiero L; Forni A; Rugiu C; Piaserico S; Fortina AB; Brunello A; Cascone C; Girolomoni G; Gomez Lira M
    Br J Dermatol; 2010 Aug; 163(2):364-70. PubMed ID: 20346027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis.
    So PL; Fujimoto MA; Epstein EH
    Mol Cancer Ther; 2008 May; 7(5):1275-84. PubMed ID: 18483315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study.
    Soufir N; Gerard B; Portela M; Brice A; Liboutet M; Saiag P; Descamps V; Kerob D; Wolkenstein P; Gorin I; Lebbe C; Dupin N; Crickx B; Basset-Seguin N; Grandchamp B
    Br J Cancer; 2006 Aug; 95(4):548-53. PubMed ID: 16909134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTCH1 +/- dermal fibroblasts isolated from healthy skin of Gorlin syndrome patients exhibit features of carcinoma associated fibroblasts.
    Valin A; Barnay-Verdier S; Robert T; Ripoche H; Brellier F; Chevallier-Lagente O; Avril MF; Magnaldo T
    PLoS One; 2009; 4(3):e4818. PubMed ID: 19287498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1+/- mice.
    Arad S; Zattra E; Hebert J; Epstein EH; Goukassian DA; Gilchrest BA
    Am J Pathol; 2008 May; 172(5):1248-55. PubMed ID: 18403589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
    Simon LS; Weaver AL; Graham DY; Kivitz AJ; Lipsky PE; Hubbard RC; Isakson PC; Verburg KM; Yu SS; Zhao WW; Geis GS
    JAMA; 1999 Nov; 282(20):1921-8. PubMed ID: 10580457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.